IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $12,604,000 | +55.8% | 3,231,753 | +313.4% | 0.01% | +50.0% |
Q3 2017 | $8,091,000 | +9.2% | 781,753 | +2.8% | 0.00% | 0.0% |
Q2 2017 | $7,412,000 | +47.2% | 760,253 | +2.7% | 0.00% | +33.3% |
Q1 2017 | $5,034,000 | +23.7% | 740,253 | 0.0% | 0.00% | +50.0% |
Q4 2016 | $4,071,000 | -33.9% | 740,253 | -8.9% | 0.00% | -33.3% |
Q3 2016 | $6,157,000 | -7.1% | 812,226 | 0.0% | 0.00% | -25.0% |
Q2 2016 | $6,628,000 | -37.2% | 812,226 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $10,559,000 | -35.3% | 812,226 | 0.0% | 0.01% | -25.0% |
Q4 2015 | $16,309,000 | +59.8% | 812,226 | -2.9% | 0.01% | +60.0% |
Q3 2015 | $10,204,000 | -40.9% | 836,426 | 0.0% | 0.01% | -37.5% |
Q2 2015 | $17,272,000 | +9.1% | 836,426 | +11.6% | 0.01% | +14.3% |
Q1 2015 | $15,827,000 | -30.3% | 749,726 | +1.6% | 0.01% | -30.0% |
Q4 2014 | $22,716,000 | +60.4% | 738,026 | -8.0% | 0.01% | +66.7% |
Q3 2014 | $14,163,000 | – | 802,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,208,210 | $16,738,232,000 | 18.66% |
ProQuest Associates IV LLC | 1,962,720 | $14,877,000 | 4.10% |
BVF INC/IL | 1,200,000 | $9,096,000 | 1.71% |
Abingworth LLP | 197,300 | $1,494,000 | 1.43% |
NEXTHERA CAPITAL LP | 305,000 | $2,312,000 | 1.42% |
Cormorant Asset Management, LP | 432,990 | $3,282,000 | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 203,000 | $1,539,000 | 0.25% |
DAFNA Capital Management LLC | 40,000 | $303,000 | 0.21% |
Monashee Investment Management LLC | 50,000 | $379,000 | 0.13% |
Eventide Asset Management | 180,000 | $1,364,000 | 0.08% |